ArticleTherapeutic advances in medical oncology2020

Surrogate endpoints for overall survival in anti-programmed death-1 and anti-programmed death ligand 1 trials of advanced melanoma.

Run-Cong Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.